BSX vs ISRG
BSX and ISRG side by side — valuation & fundamentals (public data).
Key statistics
| Metric | BSXBOSTON SCIENTIFIC CORPORATION | ISRGIntuitive Surgical, Inc. |
|---|---|---|
| Market cap | $64.26B | $151.37B |
| P/E (TTM) | 18.7 | 52.8 |
| P/B | 2.51 | 9.47 |
| P/S | 3.1x | 15.1x |
| Revenue | $21.07B(TTM) | $11.58B(TTM) |
| Revenue growth (YoY) | 19.9% | 20.5% |
| Net income | $3.49B(TTM) | $2.96B(TTM) |
| Earnings growth (YoY) | 56.7% | 23.0% |
| EPS, diluted | $2.37(TTM) | $8.27(TTM) |
| EBIT margin | 18.0% | 29.3% |
| ROE | 11.3% | 17.9% |
| ROIC | 10.0% | — |
| Piotroski F | 8/9 | — |
| 1y total return | -56.8% | -18.1% |
Figures from SEC filings · for reference only · not investment advice
Growth of $10,000: BSX vs ISRG
| Metric | BSX | ISRG |
|---|---|---|
| End value | $19.0K | $59.4K |
| Total return | +89.6% | +494.5% |
| CAGR | +6.4% | +18.8% |
| Volatility | 27.6% | 32.8% |
| Sharpe | 0.21 | 0.56 |
| Sortino | 0.29 | 0.82 |
| Max drawdown | -61.5% | -49.9% |
Based on 2600 common trading days, 2016-06-30 → 2026-11-02 · risk-free 4.16% (current short-Treasury, held constant)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)